Wecure-D Syrup is a combination pharmaceutical formulation containing Chlorpheniramine Maleate (2mg/5ml) and Dextromethorphan Hydrobromide (10mg/5ml), designed for the symptomatic relief of cough and allergic conditions. Chlorpheniramine Maleate, an antihistamine, acts by competitively blocking H1 histamine receptors, thereby reducing allergic symptoms such as rhinorrhea, sneezing, and nasal congestion. Dextromethorphan Hydrobromide is a centrally acting antitussive agent that suppresses the cough reflex by acting on the medullary cough center without causing sedation or respiratory depression at therapeutic doses. Wecure-D Syrup is indicated for the management of cough associated with upper respiratory tract infections, allergic rhinitis, and other conditions where cough suppression and antihistaminic effects are desired. The syrup formulation allows for easy administration, particularly in pediatric and geriatric populations. Dosage should be individualized based on patient age and severity of symptoms, adhering to recommended guidelines to avoid adverse effects such as drowsiness, dizziness, or gastrointestinal disturbances. Caution is advised in patients with a history of hypersensitivity to either component, and it should be used under medical supervision in individuals with asthma, glaucoma, or prostatic hypertrophy. Wecure-D Syrup offers a balanced approach to managing cough and allergic symptoms effectively.